Hematologist and Oncologist Eugene Frenkel Dies

Frenkel investigated drug resistance in cancers and how vitamin B12 deficiency damages neurons.

Written byAshley P. Taylor
| 2 min read
eugene frenkel ut southwestern medical center

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HHematologist and oncologist Eugene Frenkel of the University of Texas Southwestern Medical Center died on June 21, 2019. He was 89. Frenkel’s research contributed to the understanding that vitamin B12 deficiency causes damage to neurons’ myelin sheath, resulting in neural dysfunction. Frenkel also studied drug resistance in breast and genitourinary cancers.

Three academic chairs at UT Southwestern and multiple cancer research funds have been established in Frenkel’s honor over the course of his career, according to a university statement.

Born in 1929 in Detroit, Michigan, Frenkel graduated from the University of Michigan Medical School in 1953. He interrupted his medical residency to serve as an officer and flight surgeon in the US Air Force. UT Southwestern recruited him to Dallas in 1962 as chief of the new Division of Hematology and Oncology. His 57-year career there ended with his death.

In the 1970s, working on animals and human tissue samples, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery